Russia registered its third vaccine and announced 120,000 doses for March – Télam

The vaccine is stored at temperatures of 2 to 8 degrees

Russia registered its third vaccine against Covid-19, a stage prior to the final phase of clinical trials, which will be called CoviVac and of which tens of thousands of doses are already expected next month.

“Starting in mid-March, the first 120,000 doses (of the third vaccine) will be available. Russia is today the only country that has three vaccines,” Prime Minister Mikhail Mishustin celebrated during a government meeting.

This third vaccine was manufactured by the Shumakov Research Center in Moscow, after the country already registered the Sputnik V vaccine in August and EpiVacCorona in October and began immunizing its population.

The first vaccine, whose announcement was considered too fast and aroused international suspicion, now has the recognition of the scientific community after a study published in the medical journal The Lancet, validated by independent experts, for its high degree of efficacy.

The Russian authorities are trying to reach production agreements around the world to meet demand. This week Moscow admitted that it could not fulfill all the orders

At the moment it is used in about 20 countries, and the Russian authorities are trying to reach production agreements around the world to meet demand. This week Moscow admitted that it could not fulfill all the requests.

“We are accelerating the production of vaccines. More than 10 million doses of Sputnik V and 80,000 of EpiVacCorona have already been produced,” Mishustin explained.

The CoviVac registry assumes that phase 3 of the trials will be passed, scheduled in March with 3,000 people, according to official sources.

Clinical trials of the vaccine were carried out in 2020 in the cities of Novosibirsk, Saint Petersburg and Kirov among 400 people.

Russia registered 4.13 million cases of COVID-19 infection, a figure that places it in fourth place in the world in number of infections, behind the United States, India and Brazil

According to the Ministry of Health, the vaccine is stored at temperatures of 2 to 8 degrees, with a shelf life of six months.

Unlike the first two, this one uses an inactive virus, a more traditional technology. Salud explained that it is a recommended vaccine for people between 18 and 60 years old, reported the AFP news agency.

Russia registered 4.13 million cases of Covid-19 infection, a figure that places it in fourth place in the world in number of infections, behind the United States, India and Brazil.

Russia registered 12,953 new infections and 480 deaths in the last 24 hours, reported the national operational center for the fight against coronavirus. With this update, the deceased reach 82,876.

.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.